SCHEMBL5755157

SCHEMBL5755157

CC(C)NC(=O)c1cn[nH]c1-c1cc2ccccc2[nH]1

nearest known ligand 0.45

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
DCAF1 Q9Y4B6 12/20 0.45
ITK Q08881 2/20 0.44
PIP5K1C O60331 1/20 0.43
BRD4 O60885 1/20 0.43
CCKAR P32238 1/20 0.42
ROCK2 O75116 1/20 0.42
CCNE1 P24864 1/20 0.42
CDK2 P24941 1/20 0.42
GSK3B P49841 1/20 0.42
RIPK1 Q13546 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5756905 0.86 BRD4 (0.45) DCAF1ITKBRD4CCNE1CDK2
SCHEMBL5753389 0.85 ITK (0.44) DCAF1ITKBRD4CCNE1CDK2
SCHEMBL5755243 0.84 ITK (0.46) ITKBRD4
SCHEMBL5756565 0.83 ITK (0.46) DCAF1ITKBRD4CCNE1CDK2
SCHEMBL6478196 0.83 KDM4E (0.55) ITKBRD4CCNE1CDK2GSK3B
SCHEMBL5752698 0.82 HSP90AA1 (0.55) ITKROCK2
SCHEMBL5759232 0.81 ITK (0.49) ITKBRD4CCNE1CDK2GSK3B
SCHEMBL5756205 0.81 KDM4E (0.47) ITKBRD4CCNE1CDK2GSK3B
SCHEMBL6488207 0.81 ALDH1A1 (0.49) ITKBRD4CCNE1CDK2GSK3B
SCHEMBL5754202 0.80 CHEK1 (0.46) DCAF1ITKBRD4GSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1648884-A2 PYRAZOLYL-INDOLE DERIVATIVES ACTIVE AS KINASE INHIBITORS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM Pharmacia Italia S.p.A. (IT) 2006-04-26 EP disclosed
WO-2005005414-A2 PYRAZOLYL-INDOLE DERIVATIVES ACTIVE AS KINASE INHIBITORS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM PHARMACIA ITALIA S.P.A. (IT) 2005-01-20 WO disclosed